Exercise Psychology Laboratory University of Georgia
Athens, Georgia, 30601, United States
NCT Number: NCT04974606
The primary purpose is to test the short-term effects of the acute consumption of two novel beverages made from coffeeberries, the fruit of the coffee plant (Coffea arabica) benchmarked against caffeine on several aspects of cognitive performance.
Preliminary studies suggest that flavanols and chlorogenic acids can enhance cognitive performance. It is unknown if drinks formulated with flavanols and chlorogenic acids (without high sugar or caffeine) improve cognition or mood to a similar extent as caffeine. Coffeeberry beverage comparisons will be made to a flavored positive control beverage containing caffeine and a flavored placebo beverage.
Looking for future studies?
Notify Me17 year–50 year
All sexes
Interventional
Not applicable
Athens, Georgia, 30601, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
10 oz bottle
10 oz bottle
Time frame: Change from baseline to 60 and 120 min post-consumption. Higher test scores are better.
Objective Cognitive Demand Battery (CDB) using Computerised Mental Performance Assessment framework tasks (COMPASS) for word and picture presentation and recall, serial 3 and 7 subtraction, Rapid Visual Information Processing (RVIP).
Time frame: Change from baseline to 60 and 120 min post-consumption. Lower fatigue score is better.
Subjective Visual Analog Scale (VAS) rating from 1-100 mm from not at all to extremely, during Cognitive Demand Battery (CDB) using Computerised Mental Performance Assessment framework tasks (COMPASS)
Time frame: Change from baseline to 60 and 120 min post-consumption. Higher alertness score is better.
Subjective Bond-Lader Visual Analog Scale (VAS) rating from 1-100 mm representing the full range of each dimension from not at all to extremely, during Cognitive Demand Battery (CDB) Visual Analog Scale (VAS) rating from 1-100 mm during Cognitive Demand Battery(CDB) within Computerised Mental Performance Assessment framework tasks (COMPASS)
Time frame: Change from baseline to 60 and 120 min post-consumption. Higher calmness score is better.
Subjective Bond-Lader Visual Analog Scale (VAS) rating from 1-100 representing the full range of each dimension from not at all to extremely, during Cognitive Demand Battery (CDB)during Cognitive Demand Battery (CDB) Visual Analog Scale (VAS) rating from 1-100 mm during Cognitive Demand Battery(CDB) within Computerised Mental Performance Assessment framework tasks (COMPASS)
Time frame: Change from baseline to 60 and 120 min post-consumption. Higher contentedness score is better.
Subjective Bond-Lader Visual Analog Scale (VAS) rating from 1-100 mm representing the full range of each dimension from not at all to extremely, during Cognitive Demand Battery (CDB)during Cognitive Demand Battery (CDB) Visual Analog Scale (VAS) rating from 1-100 mm during Cognitive Demand Battery(CDB) within Computerised Mental Performance Assessment framework tasks (COMPASS)
Time frame: Change from baseline to 60 and 120 min post-consumption. Higher motivation score is better.
Subjective Visual Analog Scale (VAS) rating from 1-100 mm from not at all to extremely, during Cognitive Demand Battery (CDB) within Computerised Mental Performance Assessment framework tasks (COMPASS)
Time frame: Change from baseline to 60 and 120 min post-consumption. Stronger feelings of mental and physical energy are better.
Subjective mental and physical state energy and fatigues scales (EFS-State Scale). Composite scores range from 0 to 300 mm, from feelings of no energy to strongest feelings of energy during Cognitive Demand Battery (CDB) using Computerised Mental Performance Assessment framework tasks (COMPASS)
PepsiCo Global R&D
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06951815
Behavior, Behavioral Symptoms
Manchester, United Kingdom
View Trial DetailsNCT06281795
Behavior, Behavioral Symptoms
Krasnodar, Russia
View Trial DetailsNCT06965491
Behavior, Behavioral Symptoms
Leuven, Vlaams-Brabant, Belgium
View Trial DetailsNCT05116332
Behavior, Behavioral Symptoms
Blackburn, Lancashire, United Kingdom
View Trial Details